Assessment of a fluoroquinolone, three beta-lactams, two aminoglycosides, and a cycline in treatment of murine Yersinia pestis infection.
about
Yersinia pestis--etiologic agent of plagueGeneration of Yersinia pestis attenuated strains by signature-tagged mutagenesis in search of novel vaccine candidatesIdentification and characterization of the hemophore-dependent heme acquisition system of Yersinia pestisAntibiotic treatment of experimental pneumonic plague in miceUse of aminoglycosides in treatment of infections due to intracellular bacteriaTreatment of plague with gentamicin or doxycycline in a randomized clinical trial in Tanzania.Arthropod-transmitted infectious diseases of cats.Use of an in vitro pharmacodynamic model to derive a moxifloxacin regimen that optimizes kill of Yersinia pestis and prevents emergence of resistance.Efficacy of ciprofloxacin-gentamicin combination therapy in murine bubonic plague.Comparative efficacies of candidate antibiotics against Yersinia pestis in an in vitro pharmacodynamic model.Resistance of Yersinia pestis to antimicrobial agents.In vitro antimicrobial susceptibilities of strains of Yersinia pestisAssessment of two penicillins plus beta-lactamase inhibitors versus cefotaxime in treatment of murine Klebsiella pneumoniae infectionsIn vitro activities of 14 antibiotics against 100 human isolates of Yersinia pestis from a southern African plague focus.High-throughput, signature-tagged mutagenic approach to identify novel virulence factors of Yersinia pestis CO92 in a mouse model of infection.Impact of resistance selection and mutant growth fitness on the relative efficacies of streptomycin and levofloxacin for plague therapy.Redefining the differences in gene content between Yersinia pestis and Yersinia pseudotuberculosis using large-scale comparative genomics.Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults.Interactions of Yersinia pestis penicillin-binding proteins with beta-lactam antibiotics.Plague--clinical features and management.
P2860
Q29619320-A14985A2-0D70-4653-8097-335BDA1B3C3DQ31037921-74F69DE2-C64E-42F8-B26F-416A0AAC8A5FQ33552328-6DC4D598-C7C6-4782-AC32-DE4543198B3CQ33691477-F8B95AAC-764C-4B0F-A70E-E824BEEEEBB1Q33983252-905CF186-0B45-4AEA-AAD8-CC866A51C495Q33993221-04DD3458-EFE7-49F3-BEF3-9051456F37B0Q34497985-1AA55DDE-DABC-4526-8772-8EF05F89DA52Q34529303-94239C75-12D2-43D1-80B8-AD4E43590B5AQ34534012-639387A0-C1F6-4850-B548-F0301DDB5BFFQ35005186-B642AEB8-2C8E-4229-A81E-8E1176D880BDQ35091541-912F3BD6-5B15-4EE5-85C6-3EA26A5B9DBFQ35118853-C9617F58-DC0B-41AA-B615-4FB6DBADBCDEQ35122283-8724A2D1-A133-4C94-A8E1-F98029FB1906Q35129424-A1B31A5E-C04E-494E-A045-B913A2CED8E7Q35439470-C51BD0B7-9FBB-4EB9-9F0C-9B760040F78DQ35912654-3A38D4A2-85B6-4DF4-955D-837F39103AA8Q37658051-4E9790C8-75DC-475B-968F-352CD3F752CBQ37868241-7C0B3F05-BF0F-496A-B2F7-DC0A2000C0F6Q39780258-AABB7E95-AE77-4555-A6A7-27E3487B9A5CQ41497846-CDB49D93-7531-4301-8867-838889A95C39
P2860
Assessment of a fluoroquinolone, three beta-lactams, two aminoglycosides, and a cycline in treatment of murine Yersinia pestis infection.
description
1994 nî lūn-bûn
@nan
1994 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի մարտին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Assessment of a fluoroquinolon ...... ine Yersinia pestis infection.
@ast
Assessment of a fluoroquinolon ...... ine Yersinia pestis infection.
@en
type
label
Assessment of a fluoroquinolon ...... ine Yersinia pestis infection.
@ast
Assessment of a fluoroquinolon ...... ine Yersinia pestis infection.
@en
prefLabel
Assessment of a fluoroquinolon ...... ine Yersinia pestis infection.
@ast
Assessment of a fluoroquinolon ...... ine Yersinia pestis infection.
@en
P2093
P2860
P356
P1476
Assessment of a fluoroquinolon ...... ine Yersinia pestis infection.
@en
P2093
Amouroux JH
Bonacorsi SP
Guiyoule A
Scavizzi MR
P2860
P304
P356
10.1128/AAC.38.3.481
P407
P577
1994-03-01T00:00:00Z